Identifying Genetic Targets in Gynecological Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This observational study aims to identfy genetic targets involved in the pathogenesis of gynecological tumors, with a focus on high-grade serous ovarian carcinoma. Using a triple approach - in silico, ex vivo and in vitro - the study will investigate the role of gonadotropins and their related signaling pathways in the epithelial ovarian cancers. Gene and protein expression levels will be evaluated through transcriptomic analysis, immunohistochemistry and functional assays on tumor cell lines. The goal is to uncover potential diagnostic or therapeutic targets in gynecological malignancies.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta w wieku 18 lat lub więcej
- •Potwierdzony rozpoznaniem raka jajnika (wysoko lub nisko zaawansowany, różne typy)
- •Podpisana zgoda na udział w badaniu lub zatwierdzona zgoda etyczna
✗ Disqualifies
- •Brak chęci podpisania zgody na udział w badaniu
- •Niski stopień zaawansowania nowotworu jajnika lub nowotwór innego typu
- •Brak dostępu do wyników badań i danych medycznych pacjentki
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
Trial contact
Beatrice Melli, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.